Generation of a Zebrafish Knock-In Model Recapitulating Childhood ETV6::RUNX1-Positive B-Cell Precursor Acute Lymphoblastic Leukemia

被引:0
|
作者
Zapilko, Veronika [1 ]
Moisio, Sanni [2 ]
Parikka, Mataleena [3 ]
Heinaniemi, Merja [2 ]
Lohi, Olli [1 ,4 ,5 ]
机构
[1] Tampere Univ, Fac Med & Hlth Technol, Tampere Ctr Child Adolescent & Maternal Hlth Res, Tampere 33100, Finland
[2] Univ Eastern Finland, Inst Biomed, Kuopio 70210, Finland
[3] Tampere Univ, Fac Med & Hlth Technol, Lab Infect Biol, Tampere 33100, Finland
[4] Tampere Univ Hosp, Dept Pediat, Wellbeing Serv Cty Pirkanmaa, Tampere 33520, Finland
[5] Tampere Univ Hosp, Tays Canc Ctr, Wellbeing Serv Cty Pirkanmaa, Tampere 33520, Finland
基金
芬兰科学院;
关键词
childhood pB-ALL; disease model; CRISPR/Cas9-based knock-in; zebrafish; CHROMOSOME TRANSLOCATIONS; EMBRYONIC-DEVELOPMENT; TEL GENE; TEL-AML1; FUSION; MECHANISMS; TRANSPOSON; EVOLUTION; REARRANGEMENTS; HEMATOPOIESIS;
D O I
10.3390/cancers15245821
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Despite remarkable progress in the treatment of acute lymphoblastic leukemia (ALL) in recent years, it remains a significant contributor to pediatric cancer-related deaths. This highlights the urgent need for innovative therapeutic strategies that target the genetic alterations driving ALL. We built a novel zebrafish disease model for ETV6::RUNX1-positive ALL, which harbors secondary lesions in the two commonly mutated genes, pax5, and cdkn2a/b. The introduction of secondary mutations significantly augmented the incidence of disease. This model provides a valuable tool for investigating the etiological role of secondary mutations and facilitating the evaluation of drug sensitivities in the future.Abstract Approximately 25% of children with B-cell precursor acute lymphoblastic leukemia (pB-ALL) harbor the t(12;21)(p13;q22) translocation, leading to the ETV6::RUNX1 (E::R) fusion gene. This translocation occurs in utero, but the disease is much less common than the prevalence of the fusion in newborns, suggesting that secondary mutations are required for overt leukemia. The role of these secondary mutations remains unclear and may contribute to treatment resistance and disease recurrence. We developed a zebrafish model for E::R leukemia using CRISPR/Cas9 to introduce the human RUNX1 gene into zebrafish etv6 intron 5, resulting in E::R fusion gene expression controlled by the endogenous etv6 promoter. As seen by GFP fluorescence at a single-cell level, the model correctly expressed the fusion protein in the right places in zebrafish embryos. The E::R fusion expression induced an expansion of the progenitor cell pool and led to a low 2% frequency of leukemia. The introduction of targeted pax5 and cdkn2a/b gene mutations, mimicking secondary mutations, in the E::R line significantly increased the incidence in leukemia. Transcriptomics revealed that the E::R;pax5mut leukemias exclusively represented B-lineage disease. This novel E::R zebrafish model faithfully recapitulates human disease and offers a valuable tool for a more detailed analysis of disease biology in this subtype.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] Modeling the process of childhood ETV6-RUNX1 B-cell leukemias
    Rodriguez-Hernandez, Guillermo
    Schaefer, Daniel
    Gavilan, Ana
    Vicente-Duenas, Carolina
    Hauer, Julia
    Borkhardt, Arndt
    Sanchez-Garcia, Isidro
    ONCOTARGET, 2017, 8 (60) : 102674 - 102680
  • [22] Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia
    Lilljebjorn, Henrik
    Henningsson, Rasmus
    Hyrenius-Wittsten, Axel
    Olsson, Linda
    Orsmark-Pietras, Christina
    von Palffy, Sofia
    Askmyr, Maria
    Rissler, Marianne
    Schrappe, Martin
    Cario, Gunnar
    Castor, Anders
    Pronk, Cornelis J. H.
    Behrendtz, Mikael
    Mitelman, Felix
    Johansson, Bertil
    Paulsson, Kajsa
    Andersson, Anna K.
    Fontes, Magnus
    Fioretos, Thoas
    NATURE COMMUNICATIONS, 2016, 7
  • [23] Involvement of der(12)t(12;21)(p13;q22) and as well as additional rearrangements of chromosome 12 homolog in ETV6/RUNX1-positive acute lymphoblastic leukemia
    Stanchescu, Racheli
    Betts, David R.
    Rechavi, Gideon
    Amariglio, Ninette
    Trakhtenbrot, Luba
    CANCER GENETICS AND CYTOGENETICS, 2009, 190 (01) : 26 - 32
  • [24] Novel ETV6-RUNX1 Mouse Model to Study the Role of ELF-MF in Childhood B-Acute Lymphoblastic Leukemia: a Pilot Study
    Campos-Sanchez, Elena
    Vicente-Duenas, Carolina
    Rodriguez-Hernandez, Guillermo
    Capstick, Myles
    Kuster, Niels
    Dasenbrock, Clemens
    Sanchez-Garcia, Isidro
    Cobaleda, Cesar
    BIOELECTROMAGNETICS, 2019, 40 (05) : 343 - 353
  • [25] Frequencies of ETV6 RUNX1 Fusion and Hyperdiploidy in Pediatric Acute Lymphoblastic Leukemia Are Lower in Far East Than West
    Liang, Der-Cherng
    Shih, Lee-Yung
    Yang, Chao-Ping
    Hung, Iou-Jih
    Liu, Hsi-Che
    Jaing, Tang-Her
    Yeh, Ting-Chi
    Liang, Sung-Tzu
    Chang, Chia-Ling
    Lee, En-Hui
    Lai, Chung Liang
    Chang, Wan-Hui
    PEDIATRIC BLOOD & CANCER, 2010, 55 (03) : 430 - 433
  • [26] Presenting features of 201 children with acute lymphoblastic leukemia:: Comparison according to presence or absence of ETV6/RUNX1 rearrangement
    Alvarez, Yolanda
    Caballin, M. R.
    Gaitan, S.
    Perez, A.
    Bastida, P.
    Ortega, J. J.
    Cervera, J.
    Verdeguer, A.
    Tasso, M.
    Aventin, A.
    Badell, I.
    Guitart, M.
    Melo, M.
    Granada, I.
    Javier, G.
    Dastugue, N.
    Robert, A.
    Coll, M. D.
    CANCER GENETICS AND CYTOGENETICS, 2007, 177 (02) : 161 - 163
  • [27] B-cell acute lymphoblastic leukemia in patients with germline RUNX1 mutations
    Six, Kathryn A.
    Gerdemann, Ulrike
    Brown, Anna L.
    Place, Andrew E.
    Cantor, Alan B.
    Kutny, Matthew A.
    Avagyan, Serine
    BLOOD ADVANCES, 2021, 5 (16) : 3199 - 3202
  • [28] Simultaneous occurrence of ETV6-RUNX1 and BCR-ABL1 (e1a2) transcripts in a child with B-cell acute lymphoblastic leukemia
    Balatzenko, Gueorgui
    Guenova, Margarita
    Kalinova, Ivelina
    Belcheva, Milena
    Hristozova, Hristina
    Kaleva, Valeria
    CANCER GENETICS, 2013, 206 (03) : 97 - 101
  • [29] RNA binding protein IGF2BP1 synergizes with ETV6-RUNX1 to drive oncogenic signaling in B-cell Acute Lymphoblastic Leukemia
    Sharma, Gunjan
    Tran, Tiffany M.
    Bansal, Ishu
    Beg, Mohammad Sabique
    Bhardwaj, Ruchi
    Bassi, Jaspal
    Tan, Yuande
    Jaiswal, Amit Kumar
    Tso, Christine
    Jain, Ayushi
    Singh, Jay
    Chattopadhyay, Parthaprasad
    Singh, Archna
    Chopra, Anita
    Bakhshi, Sameer
    Casero, David
    Rao, Dinesh S.
    Palanichamy, Jayanth Kumar
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [30] ETV6/RUNX1 Fusion Gene Abrogation Decreases the Oncogenicity of Tumour Cells in a Preclinical Model of Acute Lymphoblastic Leukaemia
    Montano, Adrian
    Ordonez, Jose Luis
    Alonso-Perez, Veronica
    Hernandez-Sanchez, Jesus
    Santos, Sandra
    Gonzalez, Teresa
    Benito, Rocio
    Garcia-Tunon, Ignacio
    Hernandez-Rivas, Jesus Maria
    CELLS, 2020, 9 (01)